APOA5 抗体

Zheng, Yu, Xie, Zhao, Wu: "Apolipoprotein A5 regulates intracellular triglyceride metabolism in adipocytes." in: Molecular medicine reports, Vol. 16, Issue 5, pp. 6771-6779, (2018) (PubMed).

van den Berg, Heemskerk, Geerling, van Klinken, Schaap, Bijland, Berbée, van Harmelen, Pronk, Schreurs, Havekes, Rensen, van Dijk: "Apolipoprotein A5 deficiency aggravates high-fat diet-induced obesity due to impaired central regulation of food intake." in: FASEB journal : official publication of the Federation of American Societies for Experimental Biology, Vol. 27, Issue 8, pp. 3354-62, (2013) (PubMed).

Hubacek, Wang, Skodová, Adámková, Vráblík, Horínek, Stulc, Ceska, Talmud: "APOA5 Ala315>Val, identified in patients with severe hypertriglyceridemia, is a common mutation with no major effects on plasma lipid levels." in: Clinical chemistry and laboratory medicine : CCLM / FESCC, Vol. 46, Issue 6, pp. 773-7, (2008) (PubMed).

Dorfmeister, Zeng, Dichlberger, Nilsson, Schaap, Hubacek, Merkel, Cooper, Lookene, Putt, Whittall, Lee, Lins, Delsaux, Nierman, Kuivenhoven, Kastelein, Vrablik, Olivecrona, Schneider, Heeren et al.: "Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding. ..." in: Arteriosclerosis, thrombosis, and vascular biology, Vol. 28, Issue 10, pp. 1866-71, (2008) (PubMed).

Corella, Lai, Demissie, Cupples, Manning, Tucker, Ordovas: "APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study." in: Journal of molecular medicine (Berlin, Germany), Vol. 85, Issue 2, pp. 119-28, (2007) (PubMed).

Luo, Kranzler, Zuo, Wang, Blumberg, Gelernter: "CHRM2 gene predisposes to alcohol dependence, drug dependence and affective disorders: results from an extended case-control structured association study." in: Human molecular genetics, Vol. 14, Issue 16, pp. 2421-34, (2005) (PubMed).

OBrien, Alborn, Sloan, Ulmer, Boodhoo, Knierman, Schultze, Konrad: "The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins." in: Clinical chemistry, Vol. 51, Issue 2, pp. 351-9, (2005) (PubMed).

Prieur, Coste, Rodriguez: "The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response element." in: The Journal of biological chemistry, Vol. 278, Issue 28, pp. 25468-80, (2003) (PubMed).

Pennacchio, Olivier, Hubacek, Cohen, Cox, Fruchart, Krauss, Rubin: "An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing." in: Science (New York, N.Y.), Vol. 294, Issue 5540, pp. 169-73, (2001) (PubMed).